Solazyme Inc – Separation and Release Agreement (November 6th, 2013)
In consideration for the mutual promises and consideration provided both herein and in the Transition Agreement and Release signed September 5, 2013 (the Transition Agreement) between Harrison Dillon (the Employee) and Solazyme, Inc. (Solazyme) (collectively the Parties), the Parties hereby extend by this Separation and Release Agreement (the Separation Agreement) the release and waiver provisions therein to any and all claims that may have arisen between the execution date of the Transition Agreement and the Effective Date of this Separation Agreement, and to add such releases and waivers as provided herein, expressly including but not limited to a waiver of any federal age related claims under the ADEA.
Solazyme Inc – Transition Agreement and Release (November 6th, 2013)
This Transition Agreement and Release (Agreement) is made by and between Harrison Dillon (the Employee) and Solazyme, Inc. (Solazyme) (collectively referred to as the Parties or individually referred to as a Party).
Solazyme Inc – Consulting Agreement (November 6th, 2013)
THIS AGREEMENT (Agreement), effective as of September 30, 2013 (the Effective Date), is by and between Harrison Dillon, having a mailing address of (Consultant), and Solazyme, Inc., a Delaware corporation having a principal place of business at 225 Gateway Boulevard, South San Francisco, CA 94080 (the Company and together with Consultant may be collectively referred to hereunder as the Parties).